OCA
HELP

Octagon Capital Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Octagon Capital Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-489,596
Closed -$4.35M – 38
2024
Q3 		$4.35M Hold
489,596
– – 0.68% 28
2024
Q2 		$5.04M Hold
489,596
– – 0.79% 31
2024
Q1 		$7.69M Buy
+489,596
New +$7.07M 0.92% 31

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Octagon Capital Advisors's HELP Position: Q4 2024 in Review

Octagon Capital Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2024, closing a stake of 489,596 shares — an estimated $4.35M sold.

Octagon Capital Advisors first reported a position in HELP in Q1 2024 and held it in 3 quarters. The position peaked at $7.69M in Q1 2024. 53 funds tracked by Wall St. Rank hold HELP as of Q4 2024.

  • Octagon Capital Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Octagon Capital Advisors sold 489,596 Helus Pharma Inc. Common Stock shares in Q4 2024, an estimated $4.35M.
  • Octagon Capital Advisors first reported a position in Helus Pharma Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Octagon Capital Advisors's Helus Pharma Inc. Common Stock position peaked at $7.69M in Q1 2024.
  • 53 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2024.

Based on Octagon Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.